Journal of Medicinal Chemistry · 2004 · 213 citations · 5 references
MedicineOncologyPharmacologyCancer PharmacologyDrug DiscoveryStructure-activity RelationshipsMedicinal PlantsNatural Product Drug DiscoveryAnticancer ActivityAnticancer Compound ScreeningAnticancer Natural ProductsMarine-derived Anticancer CompoundsNatural Product Total SynthesisTotal Synthesis-derived Analogues
Neo-tanshinlactone (1) was isolated and synthesized for the first time and evaluated in vitro against several human cancer cell lines. Compound 1 showed significant inhibition against two ER+ human breast cancer cell lines and was 10-fold more potent and 20-fold more selective as compared to tamoxifen citrate. Compound 1 also potently inhibited an ER-, HER-2 overexpressing breast cancer cell line. Therefore, this novel compound merits further development as an anti-breast cancer drug candidate.
5
Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer
Dennis J. Slamon, William Godolphin, Lovell A. Jones et al. · Science · 1989 · 6.9K citations